Monitoring WT1 mRNA to Detect AML Relapse

A study shows sequential monitoring of the WT1 mRNA is of value for the early detection of hematologic relapse in patients with AML in remission. (Source: CancerNetwork)

from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2ErML89
via IFTTT